News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 841
- Sources here
- 24
- Companies here
- 16
Search results
Stored financial headlines
Active search
841 matching headlines
Ticker or company: KARMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Karyopharm Q2 Net Loss Expands; Reaffirms 2026 Revenue Guidance; Plans SNDA For Selinexor In August
(RTTNews) - Karyopharm Therapeutics Inc. (KPTI), a commercial-stage pharmaceutical company, reported financial results for the second quarter of 2026, reflecting a wider net loss and provided an update on the company's myelofibrosis program. In addition, the company reaffirmed the full-year 2026 revenue guidance. Karyopharm, …
KPTI
main company
Sharemaestro market context
Price below Trend Line
52 weeks -67.9% · Next-week setup negative 42.9%
Akari Therapeutics Q2 Results: Net loss widens to $4.8 million
Akari Therapeutics reported a net loss of $4.8 million for Q2 2026, widening from $1.9 million year-over-year, primarily due to increased R&D expenses as it advances its lead ADC candidate, AKTX-101, towards mid-2027 Phase 1 trials. The company strengthened its financial position by raising …
AKTX
main company
Sharemaestro market context
Price below Trend Line
52 weeks -79.5% · Next-week setup negative 37.7%
Judge Affirms Settlement Allowing HPE’s Deal for Juniper
A federal judge has approved a Justice Department settlement that permits Hewlett Packard Enterprise (HPE) to acquire Juniper Networks for $14 billion, despite objections from several state attorneys general. The states argued the settlement was ineffective and tainted by improper lobbying, but the judge …
HPE
main company
Sharemaestro market context
Trend signal active
52 weeks +166.8% · Next-week setup positive 56.9%
Karyopharm Therapeutics Inc. Q2 2026: Revenue $33.4M, Net loss $67M, EPS $(2.32) — 10-Q Summary
Karyopharm Therapeutics Inc. reported its Q2 2026 financial results, showing a decrease in revenue to $33.4M and an increased net loss of $67M, with a diluted loss per share of $(2.32). Despite a YoY revenue decline for the quarter, six-month net product revenue increased …
KPTI
main company
Sharemaestro market context
Price below Trend Line
52 weeks -67.9% · Next-week setup negative 42.9%
Karbon Capital Partners (KBON) earns $4.2M but flags going concern risk
Karbon Capital Partners (KBON), a Cayman Islands-based SPAC, reported a net income of $4.18 million for the six months ended June 30, 2026, primarily from interest on its Trust Account. However, the company flagged substantial doubt about its ability to continue as a going …
KBON
main company
Sharemaestro market context
Stored weekly price path
29 weeks +0.2% · Next-week setup negative 36.9%
Hewlett Packard Enterprise Co. stock outperforms competitors on strong trading day
Hewlett Packard Enterprise Co. (HPE) shares rose by 1.75% to $59.82, outperforming its competitors and the broader market on a strong trading day. The S&P 500 Index and Dow Jones Industrial Average also saw gains. This marks the second consecutive day of increases for …
HPE
main company
Sharemaestro market context
Trend signal active
52 weeks +166.8% · Next-week setup positive 56.9%
Akari Therapeutics reports Q2 2026 net loss $4.8M, raises ~$8.6M, advancing AKTX-101 toward mid-2027 Phase 1
Akari Therapeutics reported a net loss of $4.8 million for Q2 2026 and held $7.7 million in cash. The company raised approximately $8.6 million in gross proceeds through a private placement and warrant exercises. Akari is advancing its lead ADC candidate, AKTX-101, towards a …
AKTX
main company
Sharemaestro market context
Price below Trend Line
52 weeks -79.5% · Next-week setup negative 37.7%
Karyopharm Therapeutics has cash to last only into next month
Newton-based biotech Karyopharm Therapeutics is facing a severe cash crisis, with its funding expected to run out within weeks. The company also has a significant debt payment due in September, putting it at risk of default without new financing. Richard Paulson is the CEO …
KPTI
main company
Sharemaestro market context
Price below Trend Line
52 weeks -67.9% · Next-week setup negative 42.9%
Why Hewlett Packard Enterprise (HPE) is Poised to Beat Earnings Estimates Again
Hewlett Packard Enterprise (HPE) is anticipated to beat earnings estimates again, driven by a strong history of exceeding expectations, with an average surprise of 28.23% over the last two quarters. The company's positive Zacks Earnings ESP of +9.96% combined with a Zacks Rank #2 …
HPE
main company
Sharemaestro market context
Trend signal active
52 weeks +166.8% · Next-week setup positive 56.9%
What Does Hewlett Packard Enterprise (HPE) Risk From The New DDR5 ITC Case?
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Netlist has filed new patent infringement proceedings at the US International Trade Commission targeting Hewlett Packard Enterprise (NYSE:HPE) and other companies over DDR5 memory modules. The complaint …
Sharemaestro market context Trend signal active 52 weeks +139.5% · Next-week setup negative 44.5%HPE Stock Hits a 52-Week High: Is It Too Late to Buy After the Morgan Stanley Upgrade?
Quick Read Morgan Stanley upgraded HPE to Overweight with a $69 target after shares surged 159% year-to-date to a fresh 52-week high of $59. A trailing P/E of 1,263 is a goodwill-impairment illusion; the real forward P/E sits at 14 after Q2 EPS of …
HPE
main company
Sharemaestro market context
Trend signal active
52 weeks +166.8% · Next-week setup positive 56.9%
Hewlett Packard Enterprise Co Stock (HPE) Opened Up by 5.44% on Aug 13: A Full Analysis
Hewlett Packard Enterprise Co (HPE) stock rose by 5.44% due to broad sector tailwinds, demand for AI servers, and positive analyst sentiment amplified by the integration of Juniper Networks. Technical indicators showed buy signals, while fundamental analysis highlighted its strong annual revenue but negative …
HPE
main company
Sharemaestro market context
Trend signal active
52 weeks +166.8% · Next-week setup positive 56.9%
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
Karyopharm Therapeutics Inc. announced its Q2 2026 financial results, with total revenue of $33.4 million and U.S. XPOVIO net product revenue of $30.8 million, reaffirming its full-year 2026 revenue guidance. The company remains on track to submit its supplemental New Drug Application (sNDA) in …
KPTI
main company
Sharemaestro market context
Price below Trend Line
52 weeks -67.9% · Next-week setup negative 42.9%
HPE’s 11.1% week keeps the trend intact, but volume leaves the move short of full confirmation
Hewlett Packard Enterprise finished at $53.22 after a sharp weekly advance, with Relative Strength positive and the Trend Signal active, although participation lagged its recent norm.
HPE
main company
Sharemaestro market context
Trend signal active
52 weeks +166.8% · Next-week setup positive 56.9%
Envestnet Portfolio Solutions Inc. Makes New $1.08 Million Investment in Hewlett Packard Enterprise Company $HPE
Envestnet Portfolio Solutions Inc. has acquired a new stake in Hewlett Packard Enterprise Company (NYSE:HPE) worth approximately $1.08 million during the second quarter. This investment is part of a broader trend of institutional investors increasing their positions in HPE. The article also details HPE's …
HPE
main company
Sharemaestro market context
Trend signal active
52 weeks +166.8% · Next-week setup positive 56.9%
164,534 Shares in Hewlett Packard Enterprise Company $HPE Purchased by Counterpoint Mutual Funds LLC
Counterpoint Mutual Funds LLC recently acquired 164,534 shares of Hewlett Packard Enterprise (HPE) for approximately $7.42 million, making it their 24th largest holding. HPE's stock opened up 8.1% after reporting strong quarterly earnings, beating analyst estimates with EPS of $0.79 and revenue of $10.68 …
HPE
main company
Sharemaestro market context
Trend signal active
52 weeks +166.8% · Next-week setup positive 56.9%